156 related articles for article (PubMed ID: 37224999)
1. Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice.
Lallement J; Raho I; Merlen G; Rainteau D; Croyal M; Schiffano M; Kassis N; Doignon I; Soty M; Lachkar F; Krempf M; Van Hul M; Cani PD; Foufelle F; Amouyal C; Le Stunff H; Magnan C; Tordjmann T; Cruciani-Guglielmacci C
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Aug; 1868(8):159333. PubMed ID: 37224999
[TBL] [Abstract][Full Text] [Related]
2. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity.
Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS
Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481
[TBL] [Abstract][Full Text] [Related]
3. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice.
Hojjati MR; Li Z; Jiang XC
Biochim Biophys Acta; 2005 Oct; 1737(1):44-51. PubMed ID: 16216550
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response.
Kim GT; Devi S; Sharma A; Cho KH; Kim SJ; Kim BR; Kwon SH; Park TS
Exp Mol Med; 2022 May; 54(5):573-584. PubMed ID: 35513574
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
[TBL] [Abstract][Full Text] [Related]
6. Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes.
Chaurasia B; Ying L; Talbot CL; Maschek JA; Cox J; Schuchman EH; Hirabayashi Y; Holland WL; Summers SA
Mol Metab; 2021 Mar; 45():101145. PubMed ID: 33352310
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.
Lee SY; Kim JR; Hu Y; Khan R; Kim SJ; Bharadwaj KG; Davidson MM; Choi CS; Shin KO; Lee YM; Park WJ; Park IS; Jiang XC; Goldberg IJ; Park TS
J Biol Chem; 2012 May; 287(22):18429-39. PubMed ID: 22493506
[TBL] [Abstract][Full Text] [Related]
8. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.
Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH; Nikolova-Karakashian M
J Biol Chem; 2009 Mar; 284(13):8359-68. PubMed ID: 19074137
[TBL] [Abstract][Full Text] [Related]
9. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
Shah C; Yang G; Lee I; Bielawski J; Hannun YA; Samad F
J Biol Chem; 2008 May; 283(20):13538-48. PubMed ID: 18359942
[TBL] [Abstract][Full Text] [Related]
10. Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor.
Tveter KM; Villa-Rodriguez JA; Cabales AJ; Zhang L; Bawagan FG; Duran RM; Roopchand DE
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32771984
[TBL] [Abstract][Full Text] [Related]
11. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.
Chen TC; Lee RA; Tsai SL; Kanamaluru D; Gray NE; Yiv N; Cheang RT; Tan JH; Lee JY; Fitch MD; Hellerstein MK; Wang JC
J Biol Chem; 2019 Jun; 294(23):9213-9224. PubMed ID: 31053639
[TBL] [Abstract][Full Text] [Related]
12. Reducing plasma membrane sphingomyelin increases insulin sensitivity.
Li Z; Zhang H; Liu J; Liang CP; Li Y; Li Y; Teitelman G; Beyer T; Bui HH; Peake DA; Zhang Y; Sanders PE; Kuo MS; Park TS; Cao G; Jiang XC
Mol Cell Biol; 2011 Oct; 31(20):4205-18. PubMed ID: 21844222
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide.
Cantalupo A; Sasset L; Gargiulo A; Rubinelli L; Del Gaudio I; Benvenuto D; Wadsack C; Jiang XC; Bucci MR; Di Lorenzo A
Hypertension; 2020 May; 75(5):1279-1288. PubMed ID: 32172624
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2.
Chang ZQ; Lee SY; Kim HJ; Kim JR; Kim SJ; Hong IK; Oh BC; Choi CS; Goldberg IJ; Park TS
Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):44-52. PubMed ID: 21167294
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
[TBL] [Abstract][Full Text] [Related]
17. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
18. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.
Qi Y; Jiang C; Cheng J; Krausz KW; Li T; Ferrell JM; Gonzalez FJ; Chiang JY
Biochim Biophys Acta; 2015 Jan; 1851(1):19-29. PubMed ID: 24796972
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion.
Kim GT; Kim SJ; Park SH; Lee D; Park TS
J Lipid Atheroscler; 2020 May; 9(2):291-303. PubMed ID: 32821738
[TBL] [Abstract][Full Text] [Related]
20. Drug Development in the Field of Sphinogolipid Metabolism.
Qu Z; Zhou L
Adv Exp Med Biol; 2022; 1372():169-188. PubMed ID: 35503181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
